Search
for
Sort by
Research 331–360 of 957
- Elevation of circulating DNAs of disease-associated cytokines in serum cell-free DNA from patients with alopecia areata
- Hydrocolloid Use in the Treatment of Thermal Injury in a Dog
- Primary cicatricial alopecia
- Psychodermatology
- A Systematic Review of the Outcome of Hair Transplantation in Primary Scarring Alopecia
- Primary Scarring Alopecia: Clinical-Pathological Review of 72 Cases and Review of the Literature
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Novel therapies for alopecia areata: The era of rational drug development
- Primary Cicatricial Alopecia Successfully Treated with A Combination of Oral Zinc with Nd: YAG Laser. A Case Series of Five Patients
- Clinical features of 109 patients with primary cicatricial alopecia: a 15-year retrospective study
- Selection of Anti-Depressants in Geriatric Dermatoses- A Questionnaire Study of Dermatologists in Western Rajasthan, India
- Alopecia cicatrizal como manifestación de lupus eritematoso cutáneo
- Recent Japanese Studies of Trichotillomania
- E.L.F. sqare waves: a new therapy for androgenetic alopecia?
- Mechanisms regulating skin immunity and inflammation
- The Dynamics of the Skin’s Immune System
- Apoptosis in human skin development: Morphogenesis, periderm, and stem cells
- Roles for Msx and Dlx homeoproteins in vertebrate development
- Particulate matter 2.5 damages skin cells by inducing oxidative stress, subcellular organelle dysfunction, and apoptosis
- Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration
- Action of isotretinoin in acne rosacea and gram-negative folliculitis
- A Hot New Twist to Hair Biology
- Temporary hair removal by low fluence photoepilation: Histological study on biopsies and cultured human hair follicles
- Histopathology of non-scarring alopecia
- Drug-Induced Skin, Nail and Hair Disorders
- Folliculitis decalvans
- Selenoproteins Are Essential for Proper Keratinocyte Function and Skin Development
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Toxic Epidermal Necrolysis